Distinction between gene editing and genetic modification in law

Introduction

Gene editing and genetic modification are important technologies in modern biotechnology that involve altering the genetic material of living organisms. Although these terms are sometimes used interchangeably, they have different scientific meanings and may raise different legal and regulatory considerations.

Gene editing refers to targeted changes made to specific DNA sequences using technologies such as CRISPR-Cas9, TALENs, and zinc-finger nucleases. These technologies allow scientists to modify, remove, or replace particular genetic sequences. Genetic modification is a broader concept that includes introducing, removing, or altering genetic material to produce desired characteristics in an organism. It may involve introducing genetic material from another species, changing existing genes, or modifying biological characteristics through genetic engineering.

The legal distinction between these technologies is important because regulatory authorities must assess their potential effects on human health, biodiversity, agriculture, and the environment. For example, a gene-edited plant without foreign DNA may be treated differently from a genetically modified organism containing introduced genetic material under certain regulatory frameworks.

In India, the regulation of gene editing and genetic modification is primarily connected with the Environment (Protection) Act, 1986, the 1989 Genetically Engineered Organisms Rules, 1989, the Biological Diversity Act, 2002, and applicable biotechnology guidelines.

Meaning and scientific distinction

1. Gene editing

Gene editing is a biotechnology technique that enables scientists to make targeted modifications to specific DNA sequences.

The technology may involve:

Removing particular DNA sequences.

Correcting selected genetic variations.

Inserting or replacing genetic material.

Modifying genes responsible for particular biological characteristics.

CRISPR-Cas9 is one of the widely recognized gene-editing technologies.

Gene editing can sometimes produce changes without introducing foreign DNA into the final organism. However, the precise outcome depends on the technique and application.

2. Genetic modification

Genetic modification is a broader term referring to deliberate changes in an organism's genetic composition through genetic engineering.

It may involve transferring genetic material between different species or modifying existing genetic sequences.

For example, genetically modified crops may contain introduced genetic material that provides resistance to particular insects or herbicides.

Genetic modification may be used in agriculture, medicine, pharmaceutical manufacturing, and industrial biotechnology.

Major differences between gene editing and genetic modification

It is important to understand that gene editing can itself constitute genetic modification in the broader scientific and legal sense. Therefore, the two categories are not completely separate.

Legal framework governing gene editing and genetic modification in India

1. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the statutory foundation for regulating activities involving genetically engineered organisms and environmental risks.

Section 3 empowers the Central Government to take measures for environmental protection.

Section 6 enables the government to make rules concerning environmental protection and hazardous substances.

Section 8 regulates the handling of hazardous substances according to prescribed safeguards.

This legislation provides the basis for regulating specified activities involving genetically engineered organisms and microorganisms.

2. Rules, 1989 concerning genetically engineered organisms

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989, are particularly important.

These rules establish regulatory requirements for activities involving genetically engineered organisms.

They provide for several regulatory bodies:

Institutional Biosafety Committee (IBSC): Supervises relevant biotechnology activities at the institutional level.

Review Committee on Genetic Manipulation (RCGM): Monitors specified research and development activities.

Genetic Engineering Appraisal Committee (GEAC): Evaluates specified activities involving genetically engineered organisms.

State Biotechnology Coordination Committee (SBCC): Performs state-level monitoring functions.

District Level Committee (DLC): Performs district-level monitoring functions.

The regulatory treatment of gene-edited organisms depends on the specific technology, characteristics of the resulting organism, and applicable government exemptions or guidelines.

3. Guidelines for genome-edited plants, 2022

India issued the Guidelines for Safety Assessment of Genome Edited Plants, 2022.

These guidelines establish a differentiated regulatory approach for certain genome-edited plants.

They distinguish between specified categories of genome-edited plants, including SDN-1 and SDN-2, and other genetic engineering applications.

Certain qualifying SDN-1 and SDN-2 genome-edited plants may be exempted from specified biosafety requirements under the 1989 Rules, subject to applicable conditions.

However, this does not mean that every gene-edited organism is automatically exempt from regulation.

4. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources and associated traditional knowledge.

Biotechnology companies and researchers working with biological resources must consider applicable access, approval, and benefit-sharing requirements.

Gene editing and genetic modification projects may therefore raise biodiversity-related legal issues, particularly where commercial research uses biological resources obtained from India.

5. Patents Act, 1970

The Patents Act, 1970 governs patentability and protection of biotechnology inventions.

Section 3(c) excludes the mere discovery of a living thing or non-living substance occurring in nature.

Section 3(j) excludes plants and animals in whole or any part thereof, other than microorganisms, and essentially biological processes for production or propagation of plants and animals.

Section 48 establishes the rights of patentees.

Section 64 provides grounds for patent revocation.

Gene-editing tools, engineered microorganisms, and certain biotechnology processes may qualify for patent protection if they satisfy the statutory requirements of novelty, inventive step, industrial applicability, and other applicable conditions.

Legal implications of gene editing

1. Regulatory approval

Gene-edited organisms may require regulatory assessment depending on the technique used and the resulting genetic characteristics.

For example, gene-edited agricultural plants may fall within the differentiated framework established under India's 2022 genome-editing guidelines.

Human gene-editing research raises additional ethical and regulatory concerns, particularly where germline cells or embryos are involved.

2. Biosafety and environmental protection

Gene editing may create unintended genetic changes or environmental consequences.

Regulatory authorities must consider the organism's characteristics, potential ecological effects, and intended application.

The precautionary principle is relevant when scientific uncertainty exists regarding environmental risks.

3. Intellectual property rights

Disputes may arise concerning ownership of gene-editing technologies, patent licensing, research inventions, and commercial applications.

Companies must comply with patent law and contractual obligations when using protected technologies.

4. Human rights and ethical concerns

Human gene editing raises questions concerning bodily autonomy, informed consent, genetic privacy, equality, and the ethical limits of scientific intervention.

Germline editing is particularly controversial because genetic changes may be inherited by future generations.

Legal implications of genetic modification

1. Regulation of genetically modified organisms

Genetically modified organisms may be subject to regulatory assessment under the 1989 Rules.

The purpose is to evaluate potential effects on human health, biodiversity, and the environment.

2. Agricultural regulation

Genetically modified crops raise legal questions concerning biosafety, seed commercialization, farmers' rights, biodiversity, and environmental protection.

Their commercial release must comply with applicable regulatory requirements.

3. Liability for environmental damage

Organizations involved in genetic modification may face legal consequences where their activities cause environmental harm or violate biosafety requirements.

Environmental liability principles may apply depending on the circumstances.

4. Food safety and consumer protection

Genetically modified food products must comply with applicable food safety requirements.

Regulatory oversight is important to ensure that products entering the market satisfy relevant safety and labelling standards.

Important case laws

1. Aruna Rodrigues v. Union of India (2012 onwards)

This litigation concerns the regulation of genetically modified crops, particularly Bt brinjal and other GM crop-related issues.

The petition raised concerns involving biosafety assessment, environmental protection, regulatory transparency, and the potential consequences of genetically modified organisms.

The Supreme Court proceedings have involved consideration of expert recommendations and the need for appropriate biosafety safeguards.

Relevance: This litigation is important for understanding the legal regulation of genetic modification in India. It highlights the importance of scientific assessment, transparency, and precaution before permitting potentially risky biotechnology applications.

2. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

The Supreme Court examined disputes involving Monsanto's Bt cotton technology, patent rights, and the relationship between patent law and plant variety legislation.

The Court set aside the Delhi High Court judgment and remanded the matter for fresh consideration, leaving the substantive patentability questions open.

Relevance: The case demonstrates how genetic engineering technologies create disputes involving patents, biotechnology licensing, agricultural innovation, and commercial rights.

3. Novartis AG v. Union of India (2013)

The Supreme Court examined the patentability of a modified form of imatinib mesylate under Section 3(d) of the Patents Act, 1970.

The Court held that the claimed invention did not satisfy the enhanced therapeutic efficacy requirement under Section 3(d).

Relevance: Although the case did not directly concern gene editing, it establishes important principles for biotechnology and pharmaceutical patent protection. It demonstrates that technological modifications must satisfy statutory patentability requirements before receiving exclusive legal protection.

4. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court emphasized the importance of scientific expertise in environmental decision-making and discussed the difficulties associated with scientific uncertainty.

Relevance: Gene editing and genetic modification may produce environmental consequences that require specialized scientific assessment. This judgment supports the use of scientific experts in evaluating biosafety and environmental risks.

5. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognized the precautionary principle and polluter pays principle as important components of Indian environmental law.

Relevance: The precautionary principle is important when assessing genetically modified organisms and gene-edited organisms whose long-term environmental effects may be uncertain. Appropriate preventive measures should be adopted to minimize potential environmental damage.

International legal position

Different countries adopt different regulatory approaches to gene editing and genetic modification.

European Union: The European Court of Justice, in Confédération paysanne v. Premier ministre (2018), held that organisms obtained through newer mutagenesis techniques generally fall within the EU GMO legislation, subject to the framework's limited exemptions.

United States: The regulatory approach involves multiple agencies, including the USDA, FDA, and EPA, depending on the organism, product, and intended application.

United Kingdom: The Genetic Technology (Precision Breeding) Act 2023 establishes a differentiated framework for certain precision-bred organisms in England.

These approaches demonstrate that the legal distinction between gene editing and genetic modification depends not only on scientific methods but also on the regulatory definitions adopted by individual jurisdictions.

Challenges in legal regulation

Several challenges arise when distinguishing gene editing from genetic modification.

Scientific uncertainty: Gene-editing technologies may create unintended genetic changes.

Regulatory differences: Countries adopt different definitions and approval requirements.

Patent disputes: Ownership of gene-editing technologies and biological inventions can create complex litigation.

Environmental concerns: Modified organisms may affect biodiversity and ecological balance.

Ethical questions: Human germline editing raises concerns about future generations and human dignity.

Consumer awareness: Consumers may lack adequate information about genetically modified and gene-edited products.

Regulatory gaps: Rapid technological developments may create difficulties for existing legislation.

Conclusion

Gene editing and genetic modification are closely connected biotechnology concepts, but they differ in their scope, techniques, and potential regulatory treatment. Gene editing generally involves targeted changes to specific DNA sequences, whereas genetic modification is a broader category covering different forms of deliberate genetic alteration.

In India, the Environment (Protection) Act, 1986, the 1989 Genetically Engineered Organisms Rules, the Biological Diversity Act, 2002, and the 2022 Guidelines for Safety Assessment of Genome Edited Plants provide important legal foundations for regulating these technologies.

Judicial decisions such as Aruna Rodrigues v. Union of India, Monsanto Technology LLC v. Nuziveedu Seeds Ltd., and Vellore Citizens' Welfare Forum v. Union of India highlight the importance of biosafety, intellectual property protection, environmental responsibility, and scientific assessment.

Ultimately, the legal distinction between gene editing and genetic modification must be determined by examining the actual technology, the resulting organism, the intended application, and the applicable regulatory framework. A balanced legal approach should encourage scientific innovation while protecting human health, biodiversity, environmental safety, and ethical values.